These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 18422342

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Combinatorial active-site variants confer sustained clavulanate resistance in BlaC β-lactamase from Mycobacterium tuberculosis.
    Egesborg P, Carlettini H, Volpato JP, Doucet N.
    Protein Sci; 2015 Apr; 24(4):534-44. PubMed ID: 25492589
    [Abstract] [Full Text] [Related]

  • 3. New Conformations of Acylation Adducts of Inhibitors of β-Lactamase from Mycobacterium tuberculosis.
    Tassoni R, Blok A, Pannu NS, Ubbink M.
    Biochemistry; 2019 Feb 19; 58(7):997-1009. PubMed ID: 30632739
    [Abstract] [Full Text] [Related]

  • 4. Hydrolysis of clavulanate by Mycobacterium tuberculosis β-lactamase BlaC harboring a canonical SDN motif.
    Soroka D, Li de la Sierra-Gallay I, Dubée V, Triboulet S, van Tilbeurgh H, Compain F, Ballell L, Barros D, Mainardi JL, Hugonnet JE, Arthur M.
    Antimicrob Agents Chemother; 2015 Sep 19; 59(9):5714-20. PubMed ID: 26149997
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. X-ray structure of the Asn276Asp variant of the Escherichia coli TEM-1 beta-lactamase: direct observation of electrostatic modulation in resistance to inactivation by clavulanic acid.
    Swarén P, Golemi D, Cabantous S, Bulychev A, Maveyraud L, Mobashery S, Samama JP.
    Biochemistry; 1999 Jul 27; 38(30):9570-6. PubMed ID: 10423234
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Can inhibitor-resistant substitutions in the Mycobacterium tuberculosis β-Lactamase BlaC lead to clavulanate resistance?: a biochemical rationale for the use of β-lactam-β-lactamase inhibitor combinations.
    Kurz SG, Wolff KA, Hazra S, Bethel CR, Hujer AM, Smith KM, Xu Y, Tremblay LW, Blanchard JS, Nguyen L, Bonomo RA.
    Antimicrob Agents Chemother; 2013 Dec 27; 57(12):6085-96. PubMed ID: 24060876
    [Abstract] [Full Text] [Related]

  • 9. NXL104 irreversibly inhibits the β-lactamase from Mycobacterium tuberculosis.
    Xu H, Hazra S, Blanchard JS.
    Biochemistry; 2012 Jun 05; 51(22):4551-7. PubMed ID: 22587688
    [Abstract] [Full Text] [Related]

  • 10. Beta-lactamases of Mycobacterium tuberculosis and Mycobacterium kansasii.
    Segura C, Salvadó M.
    Microbiologia; 1997 Sep 05; 13(3):331-6. PubMed ID: 9353752
    [Abstract] [Full Text] [Related]

  • 11. Meropenem-clavulanate is effective against extensively drug-resistant Mycobacterium tuberculosis.
    Hugonnet JE, Tremblay LW, Boshoff HI, Barry CE, Blanchard JS.
    Science; 2009 Feb 27; 323(5918):1215-8. PubMed ID: 19251630
    [Abstract] [Full Text] [Related]

  • 12. Crystal structure of extended-spectrum beta-lactamase Toho-1: insights into the molecular mechanism for catalytic reaction and substrate specificity expansion.
    Ibuka AS, Ishii Y, Galleni M, Ishiguro M, Yamaguchi K, Frère JM, Matsuzawa H, Sakai H.
    Biochemistry; 2003 Sep 16; 42(36):10634-43. PubMed ID: 12962487
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The vitro efficacy of beta-lactam and beta-lactamase inhibitors against multidrug resistant clinical strains of Mycobacterium tuberculosis.
    Dinçer I, Ergin A, Kocagöz T.
    Int J Antimicrob Agents; 2004 Apr 16; 23(4):408-11. PubMed ID: 15081094
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. β-Lactamase of Mycobacterium tuberculosis Shows Dynamics in the Active Site That Increase upon Inhibitor Binding.
    Elings W, Gaur A, Blok AJ, Timmer M, van Ingen H, Ubbink M.
    Antimicrob Agents Chemother; 2020 Feb 21; 64(3):. PubMed ID: 31871087
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244.
    Thomson JM, Distler AM, Bonomo RA.
    Biochemistry; 2007 Oct 09; 46(40):11361-8. PubMed ID: 17848099
    [Abstract] [Full Text] [Related]

  • 20. Contribution of beta-lactamases to beta-lactam susceptibilities of susceptible and multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Segura C, Salvadó M, Collado I, Chaves J, Coira A.
    Antimicrob Agents Chemother; 1998 Jun 09; 42(6):1524-6. PubMed ID: 9624510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.